3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
9
Pancreatic Neoplasms
7
Glioblastoma
7
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Osteosarcoma
2
Myelodysplastic Syndromes
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Glioma
2
Fibrolamellar hepatocellular carcinoma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Interventions
Paclitaxel
2
poly ICLC
1
pembrolizumab
1
enzalutamide
1
Taxes
1
Ribavirin
1
Radiotherapy
1
Radiation
1
Pemetrexed
1
Nivolumab
1
Jogging
1
Injections, Subcutaneous
1
High-Intensity Focused Ultrasound Ablation
1
Gemcitabine
1
Dexamethasone
1
Carboplatin
1
Calcium Dobesilate
1
Albumin-Bound Paclitaxel
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neoplasms, Squamous Cell
×
poly ICLC
×
Clear all
NCT04116320
2025-07-14
AM-003
University of Virginia
Phase 1
Terminated
5 enrolled